Clinical Trial

Add-on Diuretics in Acute Decompensated Heart Failure

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of this study is to compare the efficacy and safety of empagliflozin, acetazolamide, and metolazone as add-on therapies to loop diuretics in patients with acute decompensated heart failure.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-19.
Status change: Not Yet Recruiting → Recruiting 2026-02-02
Trial Details
NCT Number NCT07372040
Lead Sponsor Tanta University
Conditions Acute Decompensated Heart Failure
Enrollment 66 participants
Start Date 2026-02-01
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-04